Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 6
2006 3
2007 6
2008 9
2009 5
2010 5
2011 10
2012 9
2013 13
2014 5
2015 10
2016 8
2017 9
2018 17
2019 16
2020 27
2021 15
2022 18
2023 14
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study.
Baldi C, Gentileschi S, Li Gobbi F, Cazzato M, Delle Sedie A, Gaggiano C, D'Ignazio E, Lepri G, De Lorenzo C, Nannini C, Niccoli L, Panaccione A, Di Cato L, Di Matteo A, Picchianti-Diamanti A, Guiducci S, Frediani B, Benucci M. Baldi C, et al. Among authors: benucci m. Clin Exp Med. 2025 Feb 5;25(1):50. doi: 10.1007/s10238-025-01578-2. Clin Exp Med. 2025. PMID: 39909970 Free PMC article.
A case of dermatomyositis induced by SARS-CoV-2 infection.
Aimo C, Mariotti EB, Corrà A, Quintarelli L, Ruffo DI Calabria V, Bianchi B, Del Bianco E, Verdelli A, Benucci M, Caproni M. Aimo C, et al. Among authors: benucci m. Ital J Dermatol Venerol. 2024 Apr;159(2):214-215. doi: 10.23736/S2784-8671.24.07807-1. Epub 2024 Mar 4. Ital J Dermatol Venerol. 2024. PMID: 38436615 No abstract available.
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy.
D'Alessandro F, Cazzato M, Laurino E, Morganti R, Bardelli M, Frediani B, Buongarzone C, Moroncini G, Guiducci S, Cometi L, Benucci M, Ligobbi F, Marotto D, Mosca M. D'Alessandro F, et al. Among authors: benucci m. Clin Rheumatol. 2024 Feb;43(2):657-665. doi: 10.1007/s10067-023-06836-w. Epub 2023 Dec 23. Clin Rheumatol. 2024. PMID: 38135860 Free PMC article.
186 results